240 related articles for article (PubMed ID: 8413795)
1. Effect of lactate infusion on renal transport of purine bases and oxypurinol.
Yamamoto T; Moriwaki Y; Takahashi S; Nasako Y; Higashino K
Nephron; 1993; 65(1):73-6. PubMed ID: 8413795
[TBL] [Abstract][Full Text] [Related]
2. Effect of DL-sodium lactate infusion on excretion of purine bases and oxypurinol.
Yamamoto T; Moriwaki Y; Takahashi S; Nasako Y; Higashino K
Int J Clin Pharmacol Ther Toxicol; 1993 Dec; 31(12):588-92. PubMed ID: 8314359
[TBL] [Abstract][Full Text] [Related]
3. Effect of glucose infusion on the renal transport of purine bases and oxypurinol.
Moriwaki Y; Yamamoto T; Takahashi S; Suda M; Higashino K
Nephron; 1995; 69(4):424-7. PubMed ID: 7777107
[TBL] [Abstract][Full Text] [Related]
4. Plasma concentrations and urinary excretion of purine bases (uric acid, hypoxanthine, and xanthine) and oxypurinol after rigorous exercise.
Kaya M; Moriwaki Y; Ka T; Inokuchi T; Yamamoto A; Takahashi S; Tsutsumi Z; Tsuzita J; Oku Y; Yamamoto T
Metabolism; 2006 Jan; 55(1):103-7. PubMed ID: 16324927
[TBL] [Abstract][Full Text] [Related]
5. Effects of angiotensin II infusion on renal excretion of purine bases and oxypurinol.
Moriwaki Y; Yamamoto T; Tsutsumi Z; Takahashi S; Hada T
Metabolism; 2002 Jul; 51(7):893-5. PubMed ID: 12077737
[TBL] [Abstract][Full Text] [Related]
6. Effect of glucagon on renal excretion of oxypurinol and purine bases.
Yamamoto T; Moriwaki Y; Takahashi S; Tsutsumi Z; Hiroishi K; Yamakita J; Nakano T; Higashino K
J Rheumatol; 1997 Apr; 24(4):708-13. PubMed ID: 9101506
[TBL] [Abstract][Full Text] [Related]
7. Renal excretion of purine bases. Effects of probenecid, benzbromarone and pyrazinamide.
Yamamoto T; Moriwaki Y; Takahashi S; Hada T; Higashino K
Nephron; 1988; 48(2):116-20. PubMed ID: 3344050
[TBL] [Abstract][Full Text] [Related]
8. Effect of amino acids on the excretions of purine bases and oxypurinol.
Yamamoto T; Moriwaki Y; Takahashi S; Yamakita J; Higashino K
Nephron; 1996; 73(1):41-7. PubMed ID: 8742955
[TBL] [Abstract][Full Text] [Related]
9. Effect of furosemide on renal excretion of oxypurinol and purine bases.
Yamamoto T; Moriwaki Y; Takahashi S; Tsutsumi Z; Hada T
Metabolism; 2001 Feb; 50(2):241-5. PubMed ID: 11229436
[TBL] [Abstract][Full Text] [Related]
10. [Clearance of oxypurines in normal subjects and in gout patients subjected to a purine-free diet. Effects of allopurinol].
Porcelli B; Pizzichini M; Di Stefano A; Leoncini R; Taddeo A; Marinello E
Boll Soc Ital Biol Sper; 1989 Nov; 65(11):1105-10. PubMed ID: 2629828
[TBL] [Abstract][Full Text] [Related]
11. Effect of fenofibrate on plasma concentration and urinary excretion of purine bases and oxypurinol.
Yamamoto T; Moriwaki Y; Takahashi S; Tsutsumi Z; Hada T
J Rheumatol; 2001 Oct; 28(10):2294-7. PubMed ID: 11669172
[TBL] [Abstract][Full Text] [Related]
12. Effects of allopurinol on beer-induced increases in plasma concentrations and urinary excretion of purine bases (uric acid, hypoxanthine, and xanthine).
Ka T; Moriwaki Y; Inokuchi T; Yamamoto A; Takahashi S; Tsutsumi Z; Yamamoto T
Horm Metab Res; 2006 Mar; 38(3):188-92. PubMed ID: 16673211
[TBL] [Abstract][Full Text] [Related]
13. Effect of norepinephrine on the urinary excretion of purine bases and oxypurinol.
Yamamoto T; Moriwaki Y; Takahashi S; Tsutsumi Z; Hada T
Metabolism; 2001 Oct; 50(10):1230-3. PubMed ID: 11586499
[TBL] [Abstract][Full Text] [Related]
14. Effect of losartan potassium, an angiotensin II receptor antagonist, on renal excretion of oxypurinol and purine bases.
Yamamoto T; Moriwaki Y; Takahashi S; Tsutsumi Z; Hada T
J Rheumatol; 2000 Sep; 27(9):2232-6. PubMed ID: 10990239
[TBL] [Abstract][Full Text] [Related]
15. Renal clearances of purine bases and oxypurinol during glucose infusion.
Moriwaki Y; Yamamoto T; Takahashi S; Nasako Y; Hada T; Higashino K
Adv Exp Med Biol; 1994; 370():39-42. PubMed ID: 7660935
[No Abstract] [Full Text] [Related]
16. Xylitol-induced increase in the concentration of oxypurines and its mechanism.
Yamamoto T; Moriwaki Y; Takahashi S; Suda M; Higashino K
Int J Clin Pharmacol Ther; 1995 Jun; 33(6):360-5. PubMed ID: 7582389
[TBL] [Abstract][Full Text] [Related]
17. Purine metabolism in women with primary gout.
Puig JG; Mateos FA; Miranda ME; Torres RJ; de Miguel E; PĂ©rez de Ayala C; Gil AA
Am J Med; 1994 Oct; 97(4):332-8. PubMed ID: 7942934
[TBL] [Abstract][Full Text] [Related]
18. [A study on treatment of hyperuricemia--effects and kinetics of allopurinol and oxipurinol].
Hosoya T; Ichida K; Tabe A; Sakai O
Ryumachi; 1991 Feb; 31(1):28-35. PubMed ID: 1857993
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic/Pharmacodynamic Modelling of Allopurinol, its Active Metabolite Oxypurinol, and Biomarkers Hypoxanthine, Xanthine and Uric Acid in Hypoxic-Ischemic Encephalopathy Neonates.
Chu WY; Annink KV; Nijstad AL; Maiwald CA; Schroth M; Bakkali LE; van Bel F; Benders MJNL; van Weissenbruch MM; Hagen A; Franz AR; Dorlo TPC; Allegaert K; Huitema ADR;
Clin Pharmacokinet; 2022 Feb; 61(2):321-333. PubMed ID: 34617261
[TBL] [Abstract][Full Text] [Related]
20. Difference of the plasma concentration and urinary excretion of allopurinol, oxypurinol, and purine bases between dietary intake and fasting.
Yamamoto T; Moriwaki Y; Takahashi S; Tsutsumi Z; Yamakita J; Higashino K
Int J Clin Pharmacol Ther; 1996 Apr; 34(4):157-62. PubMed ID: 8861734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]